NSE: FORTIS · 30 September 2026 · Dated market coverage
- The stock is -6.33% at ₹770.00.
- Likely reason:Heavy selling and legal sentiment overhang
- Approximate traded value is₹446.01 crore.
- It is -30.27% from its 52-week high and +1.66% from its 52-week low.
- The stock is being compared withNifty Pharmaalongside the Nifty 50.
Why Is Fortis Healthcare Share Price Falling 6.33% Today?
Latest NSE EOD report: 2026-09-29. Today’s Volume: 5,792,275; 5-Day Avg. Volume: 2,859,778; 20-Day Avg. Volume: 1,375,660; Volume vs 20-Day Avg.: 4.21x; Delivery Quantity: 1,591,838; Delivery %: 62.86%; Number of Trades: 59,377.
Fortis Healthcare (FORTIS) faced severe selling pressure, sliding 6.33% to close at ₹770.00 after opening at ₹817.60. The stock traded near the bottom of its intraday range, hitting a low of ₹757.55 during the session, which matches its new 52-week low. Trading volumes spiked noticeably, with volume reaching over 4.2 times its 20-day average, signaling heavy liquidation and institutional or high-volume selling interest.
The sharp decline in Fortis significantly underperformed the broader market and its sectoral peers. While the benchmark Nifty index closed down 0.42%, the Nifty Pharma sector registered a sharper loss of 1.84%. Fortis’s deeper 6.33% fall reflects intense, stock-specific downward momentum that far outpaced the broader healthcare sector’s correction.
This steep drop comes in the wake of recent developments, including the Supreme Court allowing a forensic audit in a case involving the company, prompting Fortis to clarify that it is a ‘complete stranger’ to the underlying dispute between Daiichi and the Singh brothers. Additionally, the broader hospital and healthcare segment has faced negative sentiment due to recent regulatory scrutiny and growth concerns in key metropolitan markets.
medium confidence
- Volume was 4.21x the 20-day average, indicating intense selling pressure.
- Recent reports concerning Supreme Court proceedings and forensic audits created a negative sentiment overlay.
Ownership & Transaction Activity
The promoter/promoter-group disclosure states that the shares covered by the filing were free from encumbrance.
Source: NSE corporate filing
- Promoter group held 235,295,895 equity shares as of 31 March 2026.
- No shares were pledged or encumbered directly or indirectly during the financial year.
Source: NSE corporate disclosure. Only factual ownership/shareholding details extracted from the filing are shown.
Research & Brokerage Views
Brokerage views are third-party opinions and are not WittyTrades recommendations.
WittyTrades Data Insight
Price Position:The stock is around the middle of the day’s trading range.
Move From Open:-5.82%.
Intraday Range:7.38% of the previous close.
5-Day Performance:-13.87%; 20-Day Performance:-15.85%.
Latest Company Developments
What Should Traders and Investors Watch Next?
- Developments regarding the Supreme Court proceedings and forensic audit clarifications
- Volume trends and whether the stock finds price stabilization near its 52-week low of ₹757.55
- Execution updates on the newly signed Ashok Vihar super specialty hospital project
- Institutional delivery percentages and block deal activity
Catalyst note:The sharp price drop and high volume appear driven by compounding legal headlines and broader hospital sector weakness rather than a single same-day corporate announcement.
Frequently Asked Questions
What is the likely reason for today’s move?
The stock’s sharp 6.33% decline alongside heavy volume (over 4x its 20-day average) reflects steep liquidation, exacerbated by recent headline risks regarding Supreme Court-ordered forensic audits and broader hospital sector weakness.
Is trading volume elevated?
Today’s volume is 5,792,275. The latest 20-day average available is 1,375,660, equivalent to about 4.21x of the recent average.
Before acting on this stock
Consult your own investment adviser before acting on any security. If you are interested in stock research or other available research categories, review theWittyTrades subscription plans and research segments.
Article by:WittyTrades Research Desk